- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.07. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.07. | bioAffinity Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.07. | bioAffinity Technologies sichert sich kanadisches Patent für Lungenkrebstest | 4 | Investing.com Deutsch | ||
| 22.07. | bioAffinity Technologies secures Canadian patent for lung cancer test | 1 | Investing.com | ||
| BIOAFFINITY TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 15.07. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.05. | BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors | 3 | Insider Monkey | ||
| 27.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.05. | bioAffinity Technologies names new chief medical officer | 2 | Investing.com | ||
| 20.05. | bioAffinity Technologies appoints Gordon Downie as chief medical officer | 2 | Seeking Alpha | ||
| 19.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | bioAffinity Technologies, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 15.05. | bioAffinity Technologies GAAP EPS of -$0.16, revenue of $1.9M | 3 | Seeking Alpha | ||
| 08.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | bioAffinity Technologies completes $3.25 million offering | 1 | Investing.com | ||
| 07.05. | bioAffinity Technologies schließt Kapitalerhöhung von 3,25 Millionen US-Dollar ab | 5 | Investing.com Deutsch | ||
| 06.05. | bioAffinity kündigt Wertpapierangebot von 3,25 Millionen US-Dollar an | 9 | Investing.com Deutsch | ||
| 06.05. | bioAffinity announces $3.25 million securities offering | - | Investing.com | ||
| 05.05. | bioAffinity Technologies, Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 02.05. | bioAffinity Technologies, Inc. - S-1, General form for registration of securities | 3 | SEC Filings | ||
| 29.04. | bioAffinity Technologies, Inc. - 10-K/A, Annual Report | 1 | SEC Filings |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES | - | - | Palatin Technologies, Inc.: Palatin Announces 1-for-50 Reverse Stock Split | PRINCETON, N.J., Aug. 8, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), today announced a reverse stock split ("Reverse Stock Split") of its... ► Artikel lesen | |
| BIOXXMED | 0,650 | 0,00 % | EQS-News: bioXXmed AG informiert über die Verzögerung der Veröffentlichung des geprüften Jahresabschlusses 2024 | EQS-News: bioXXmed AG
/ Schlagwort(e): Jahresbericht
bioXXmed AG informiert über die Verzögerung der Veröffentlichung des geprüften Jahresabschlusses 2024
27.06.2025 /... ► Artikel lesen | |
| VIVOSIM LABS | 1,220 | -100,00 % | VivoSim Labs, INC. - 10-Q, Quarterly Report | ||
| OCUGEN | 0,864 | -1,91 % | Ocugen gets EMA backing for single trial of Stargardt disease therapy | ||
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| BIO-GATE | 0,880 | -8,81 % | EQS-DD: Bio-Gate AG: Thomas Konradt, Zeichnung von Wandelschuldverschreibungen | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
12.08.2025 / 17:40... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,389 | +3,18 % | Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer | Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
| VAXART | 0,306 | +4,37 % | Vaxart, Inc.: Vaxart CEO Issues Letter to Stockholders | - Management Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on September 4, 2025 - SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart,... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 1,650 | -1,20 % | Burcon NutraScience introduces protein isolate: Supplier launches FavaPro 90+, a high-purity fava protein isolate | ||
| IDORSIA | 2,830 | +4,04 % | Idorsia Pharmaceuticals Ltd: TRYVIO nominated for the 2025 Prix Galien USA "Best Pharmaceutical Product" | Allschwil, Switzerland - August 12, 2025Idorsia Ltd (SIX: IDIA) announced today that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated... ► Artikel lesen | |
| CELLECTAR BIOSCIENCES | 4,580 | 0,00 % | Cellectar Biosciences, Inc.: Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement | Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for Triple-Negative... ► Artikel lesen | |
| AFFIMED | 0,972 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
| AIM IMMUNOTECH | 0,073 | -100,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech's Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025) | There will be presentations on the latest positive progress from AIM's clinical program in pancreatic cancer, the positive therapeutic effects of AIM's drug Ampligen on multiple cancer types, and... ► Artikel lesen | |
| IMMUNIC | 0,747 | +2,61 % | EQS-News: Immunic AG: Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Issuer: Immunic AG
/ Key word(s): Quarter Results
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
07.08.2025 / 12:30 CET/CEST
The... ► Artikel lesen | |
| T2 BIOSYSTEMS | 0,250 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA... ► Artikel lesen |
Das Unternehmen BIOAFFINITY TECHNOLOGIES INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,274 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOAFFINITY TECHNOLOGIES INC finden Sie auf Wallstreet Online.